wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37604501-2B88E613-D4AC-4649-874A-E7A710FFD766
Q37604501-2B88E613-D4AC-4649-874A-E7A710FFD766
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-2B88E613-D4AC-4649-874A-E7A710FFD766
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
P433
Q37604501-2B88E613-D4AC-4649-874A-E7A710FFD766
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-2B88E613-D4AC-4649-874A-E7A710FFD766
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8b686291756c9ab815303fcfa1158383bf83d0b0
P433
1
http://www.w3.org/2001/XMLSchema#string